Extended Data Fig. 4: Immune Subsets at Screening and Recovery Post αβdepleted-HSCT.

All patients were monitored post-HSCT with immune recovery similar to previous reports with this type of donor graft (n = 3). Decreased CD19+ B-cells occurred in patient 2 at 24 weeks post-HSCT due to treatment for immune mediated hemolytic anemia and thrombocytopenia.